OverviewSuggest Edit

eNeura Inc., a privately held medical technology company, is pioneering the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine with aura patients to administer treatment as needed—at home, in the office or on the go.
The eNeura SpringTMS device is placed at the back of the head for less than a minute, generating a focused, single magnetic pulse that induces a mild electric current in the back of the brain. Leaders in the field of headache medicine believe this targeted signal depolarizes—or short circuits—the hyper-excitability in areas of the brain associated with migraine and the abnormal brainwaves typical in cortical spreading depression (CSD), which is associated with migraine aura.
Used for many years as a non-invasive method of diagnosing and studying brain activity, recent scientific evidence has demonstrated TMS is also an effective tool in treating neurological disorders. eNeura technology uses single pulse TMS, or sTMS, which is considered very safe. In fact, FDA classified sTMS as a non-significant risk over ten years ago. The magnetic field is approximately half the strength of a typical MRI device and patients do not feel the mild electric current stimulated by the sTMS Device.

HQBaltimore, US

Latest Updates

Employees (est.) (Jul 2020)10
Cybersecurity ratingDMore

Key People/Management at eNeura

David K. Rosen

David K. Rosen

CEO & Board Director
Thomas C. Hoster

Thomas C. Hoster

Terese M. Baker

Terese M. Baker

VP, Marketing
Robert Fischell

Robert Fischell

Founder, President, CTO & Board Director
Show more

eNeura Office Locations

eNeura has offices in Baltimore, Sunnyvale and London
Baltimore, US (HQ)
211 E Lombard St #212
Sunnyvale, US
715 N Pastoria Ave
London, GB
A1211, Barbican
Show all (3)

eNeura Financials and Metrics

Summary Metrics

Founding Date


eNeura total Funding

$30.9 m

eNeura latest funding size

$6.39 m

Time since last funding

5 years ago

eNeura investors

eNeura's latest funding round in March 2016 was reported to be $6.4 m. In total, eNeura has raised $30.9 m
Show all financial metrics

eNeura Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

eNeura Online and Social Media Presence

Embed Graph

eNeura News and Updates

eNeura, Inc. Receives FDA Clearance for Acute Treatment and Prevention of Migraine in Children 12 Years of Age and Older

BALTIMORE, Feb. 27, 2019 /PRNewswire/ -- eNeura, Inc., a privately held medical technology company, announced today that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new marketing clearance expands the product indication of acute and...

eNeura Frequently Asked Questions

  • When was eNeura founded?

    eNeura was founded in 2000.

  • Who are eNeura key executives?

    eNeura's key executives are David K. Rosen, Thomas C. Hoster and Terese M. Baker.

  • How many employees does eNeura have?

    eNeura has 10 employees.

  • Who are eNeura competitors?

    Competitors of eNeura include Hemex Health, Garwood Medical Devices and Biostage.

  • Where is eNeura headquarters?

    eNeura headquarters is located at 211 E Lombard St #212, Baltimore.

  • Where are eNeura offices?

    eNeura has offices in Baltimore, Sunnyvale and London.

  • How many offices does eNeura have?

    eNeura has 3 offices.